Fairmount Funds Management LLC Axsome Therapeutics, Inc. Transaction History

Fairmount Funds Management LLC

$326 Million
Q2 2025

A detailed history of Fairmount Funds Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Fairmount Funds Management LLC holds 815,176 shares of AXSM stock, worth $95.1 Million. This represents 26.09% of its overall portfolio holdings.

Number of Shares

815,176

Previous 815,176 -0.0%

Holding current value

$95.1 Million

Previous $95.1 Million 10.49%

% of portfolio

26.09%

Previous 32.39%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$80.05 - $137.75 $52.3 Million - $90.1 Million	-653,807 Reduced 44.51%	815,176 $95.1 Million
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $74 Million - $89.5 Million	-891,094 Reduced 37.76%	1,468,983 $124 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $1.08 Million - $1.58 Million	18,839 Added 0.8%	2,360,077 $188 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $259,133 - $307,629	-3,742 Reduced 0.16%	2,341,238 $164 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $19.5 Million - $30.1 Million	333,333 Added 16.57%	2,344,980 $169 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $4.59 Million - $9.17 Million	115,000 Added 6.06%	2,011,647 $155 Million
Q3 2022 Nov 09, 2022	BUY	$36.06 - $69.85 $34.4 Million - $66.6 Million	954,076 Added 101.22%	1,896,647 $84.6 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $17.9 Million - $31.2 Million	754,973 Added 402.44%	942,571 $39 Million
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $2.49 Million - $8.53 Million	-125,000 Reduced 39.99%	187,598 $6.18 Million
Q2 2021 Aug 13, 2021	BUY	$50.63 - $73.5 $3.09 Million - $4.48 Million	61,000 Added 24.25%	312,598 $21.1 Million
Q1 2021 May 14, 2021	BUY	$55.91 - $81.44 $1.76 Million - $2.57 Million	31,500 Added 14.31%	251,598 $14.2 Million
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $273,360 - $343,360	4,000 Added 1.85%	220,098 $15.7 Million
Q2 2020 Aug 04, 2020	BUY	$49.87 - $98.69 $1.32 Million - $2.62 Million	26,500 Added 13.98%	216,098 $17.8 Million
Q1 2020 May 08, 2020	BUY	$41.2 - $101.31 $7.81 Million - $19.2 Million	189,598 New	189,598 $11.2 Million

Others Institutions Holding AXSM

# of Institutions

403

Shares Held

37.3M

Call Options Held

507K

Put Options Held

540K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Account

Fairmount Funds Management LLC Axsome Therapeutics, Inc. Transaction History